Pages that link to "Q58803175"
Jump to navigation
Jump to search
The following pages link to Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations (Q58803175):
Displaying 50 items.
- Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight (Q26752583) (← links)
- Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus (Q26765245) (← links)
- Extrahepatic manifestations of chronic hepatitis C virus infection (Q26767084) (← links)
- Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality? (Q26776338) (← links)
- Assessing cardiovascular risk in hepatitis C: An unmet need (Q26784258) (← links)
- Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen (Q26861095) (← links)
- Metabolic factors and chronic hepatitis C: a complex interplay (Q27011787) (← links)
- Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV (Q28079826) (← links)
- Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis. (Q30360538) (← links)
- The effect of Hepatitis C Virus infection on cardiovascular complications in end stage kidney disease patients on regular hemodialysis (Q33620417) (← links)
- Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis. (Q33735381) (← links)
- Is hepatitis C associated with atherosclerotic burden? A systematic review and meta-analysis (Q34128534) (← links)
- Lysophosphatidic acid in atherosclerotic diseases (Q34273486) (← links)
- Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women (Q34340862) (← links)
- PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease (Q34998991) (← links)
- A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection (Q35544658) (← links)
- Endothelial dysfunction correlates with liver fibrosis in chronic HCV infection. (Q35591469) (← links)
- Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT. (Q35678746) (← links)
- Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study (Q35848217) (← links)
- Extrahepatic manifestations of hepatitis C infection: navigating CHASM. (Q36010828) (← links)
- Impact of Chronic Hepatitis C Virus Genotype 1b Infection on Triglyceride Concentration in Serum Lipoprotein Fractions. (Q36183998) (← links)
- Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population. (Q36497046) (← links)
- Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis. (Q37205022) (← links)
- Chemoprevention for hepatocellular carcinoma: the role of statins (Q37584611) (← links)
- Hepatitis C virus and cardiovascular: A review (Q37610905) (← links)
- Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms (Q37682486) (← links)
- The hepatitis C virus infection as a systemic disease (Q38052844) (← links)
- Lipids and HCV. (Q38056643) (← links)
- The predictive value of steatosis in hepatitis C virus infection (Q38085061) (← links)
- Cardiovascular diseases and HCV infection: a simple association or more? (Q38167953) (← links)
- Atherosclerosis as a possible extrahepatic manifestation of chronic hepatitis C virus infection (Q38276377) (← links)
- Hepatitis C as a risk factor for carotid atherosclerosis - a systematic review (Q38332239) (← links)
- Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy (Q38606170) (← links)
- Chronic hepatitis C virus infection: a new modifiable cardio-metabolic risk factor? (Q38638110) (← links)
- Why do I treat my patients with mild hepatitis C? (Q38685564) (← links)
- Chronic hepatitis C virus infection, a new cardiovascular risk factor? (Q38695606) (← links)
- Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients (Q38946641) (← links)
- The impact of antiviral therapy for hepatitis C on the quality of life: a perspective (Q39067380) (← links)
- Insulin resistance, steatosis and hepatitis C virus. (Q39240971) (← links)
- De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients (Q40675431) (← links)
- Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients (Q40989818) (← links)
- Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection (Q41660591) (← links)
- Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes (Q42159672) (← links)
- IRS1 Expression in Hepatic Tissue and Leukocytes in Chronic Hepatitis C Virus Infected Patients: A Comparative Study (Q42239659) (← links)
- Cardiovascular risk factors and systemic endothelial function in patients with cirrhosis. (Q43874129) (← links)
- Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress. (Q46257956) (← links)
- Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review. (Q47169604) (← links)
- Direct antiviral treatment of chronic hepatitis C in heart transplant recipients. (Q48302077) (← links)
- Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments? (Q58699647) (← links)
- The Unravelled Link between Chronic Kidney Disease and Hepatitis C Infection (Q59072614) (← links)